Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Black men diagnosed with low-grade prostate cancer have higher risk of death, study shows

Black men diagnosed with prostate cancer classified as low risk may actually have a more-aggressive form of the disease that is more likely to be fatal than in nonblack men placed in the same prognostic category, a new study suggests.

18 Dec 2018

Combination of a vaccine and checkpoint drugs reduces pancreatic tumors in mice

Researchers at the Johns Hopkins Kimmel Cancer Center discovered a combination of a cancer vaccine with two checkpoint drugs reduced pancreatic cancer tumors in mice, demonstrating a possible pathway for treatment of people with pancreatic cancers whose response to standard immunotherapy is poor.

18 Dec 2018

Metal-based chemotherapy enhances the effect of cancer immunotherapy

Due to their powerful tumor-killing effect, metal-based chemotherapies are frequently used in cancer treatment. However, it was hitherto assumed that they damaged the immune system, because of their cytotoxic (cell-damaging) effect even against dividing healthy cells.

18 Dec 2018

Scientists create patient-specific model to identify most effective treatment for appendix cancer

Scientists at the Wake Forest Institute for Regenerative Medicine have recently developed a process that may change the way cancer of the appendix is treated in the future.

17 Dec 2018

Malnutrition in children with Crohn's disease linked with increased risk of surgical complications

Results of a medical records study of children with Crohn's disease by Johns Hopkins researchers have added substantial evidence for a strong and direct link between malnutrition and increased risk of surgical complications and poor outcomes.

17 Dec 2018

CTF along with NTAP and Sage announce first-ever open data portal for neurofibromatosis

The Children's Tumor Foundation, together with the Neurofibromatosis Therapeutic Acceleration Program and Sage Bionetworks, has announced the first-ever open data portal for scientific research results in the field of neurofibromatosis.

17 Dec 2018

Eisai enters into agreement with Eurofarma for its anti-obesity agent lorcaserin

Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride in Brazil to Eurofarma Laboratorios S.A. Under this agreement, Eisai will supply Eurofarma with lorcaserin. Eisai will receive a one-time contractual payment and is eligible for milestone payments for sales in Brazil.

17 Dec 2018

Research offers hope for patients with serious bone marrow cancer

Hope has emerged for patients with a serious type of bone marrow cancer as new research into a therapeutic drug has revealed improved outcomes and survival rates.

14 Dec 2018

Study: Chronic opioid therapy associated with increased healthcare spending and hospital stays

Using data from commercial insurance claims of working-aged adults, new research published in the December issue of The American Journal of Accountable Care found that chronic opioid therapy for noncancer pain is associated with increased healthcare spending as well as hospital stays.

14 Dec 2018

World's largest AI-powered medical research network launched by OWKIN

OWKIN today announced the world's largest AI-powered medical research network. The OWKIN Loop Network is comprised of 44 prestigious hospitals and research institutions across the US and Europe, including Cleveland Clinic and Mount Sinai.

13 Dec 2018

Study assesses safety and efficacy of new treatment for pancreatic cancer

Gemcitabine given in combination with nab-paclitaxel is the standard of care for patients with advanced pancreatic cancer. This practice, however, rests on data obtained from several recent clinical trials enrolling patients with pancreatic cancer who skewed younger and in better overall condition than most.

13 Dec 2018

Unraveling the complexity of cancer biology can prompt new avenues for drug development

Unraveling the complexity of cancer biology can lead to the identification of new molecules involved in breast cancer and prompt new avenues for drug development. And proteogenomics, an integrated, multipronged approach, seems to be a way to do it.

13 Dec 2018

The EORTC Brain Tumor Group and Protagen AG collaborate to study immuno-competence of long-term glioblastoma survivors

The European Organisation for Research and Treatment of Cancer Brain Tumor Group and Protagen AG today announced a collaboration to utilize Protagen’s Cancer Immunotherapy Array to identify autoantibody biomarkers that investigate the immunological profile and immuno-competence of long-term Glioblastoma survivors.

12 Dec 2018

New collaborative partnership in quest of novel antibiotics

The Global Antibiotic Research and Development Partnership, Eisai Co., Ltd. and Takeda Pharmaceutical Company Limited have signed an agreement for GARDP to access and screen components of Eisai and Takeda's chemical libraries.

12 Dec 2018

Integral Molecular and Merus collaborate to develop bispecific antibody therapeutics

Integral Molecular, the industry leader in the discovery of monoclonal antibodies against membrane proteins, and Merus N.V., a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, announced that they have entered into a collaboration on multiple undisclosed targets.

12 Dec 2018

ESMO Immuno-Oncology Congress showcases novel technologies set to benefit many cancer patients

Innovation in immuno-oncology is exploding and new technologies that are set to benefit many patients with cancer are being showcased in the highly diverse array of topics to be discussed at the ESMO Immuno-Oncology Congress, to be held 13-16 December in Geneva, Switzerland.

11 Dec 2018

Researchers gain new insights into pediatric tumors

Peripheral nervous system tumors are one of the most common types of childhood tumors. While some of these tumors, known as neuroblastoma, disappear on their own without treatment, others will continue to grow even despite intensive treatment.

10 Dec 2018

New artificial intelligence-based system to differentiate between different types of cancer cells

In cancer patients, there can be tremendous variation in the types of cancer cells from one patient to another, even within the same disease. Identification of the particular cell types present can be very useful when choosing the treatment that would be most effective, but the methods of doing this are time-consuming and often hampered by human error and the limits of human sight.

10 Dec 2018

New data from TAILORx trial confirms lack of chemo benefit regardless of race or ethnicity

An analysis of race and ethnicity data from the TAILORx clinical trial was presented at the 2018 San Antonio Breast Cancer Symposium.

10 Dec 2018

Exercise program during adjuvant breast cancer treatment may provide cardiovascular benefits

Women who underwent a supervised program of cardiovascular exercise during adjuvant breast cancer treatment experienced better cardiovascular function than those who were not part of the exercise program, according to results of the EBBA-II trial presented at the 2018 San Antonio Breast Cancer Symposium, held Dec. 4-8.

7 Dec 2018

Oncology News and Research

Further Reading

Black men diagnosed with low-grade prostate cancer have higher risk of death, study shows

Combination of a vaccine and checkpoint drugs reduces pancreatic tumors in mice

Metal-based chemotherapy enhances the effect of cancer immunotherapy

Scientists create patient-specific model to identify most effective treatment for appendix cancer

Malnutrition in children with Crohn's disease linked with increased risk of surgical complications

CTF along with NTAP and Sage announce first-ever open data portal for neurofibromatosis

Eisai enters into agreement with Eurofarma for its anti-obesity agent lorcaserin

Research offers hope for patients with serious bone marrow cancer

Study: Chronic opioid therapy associated with increased healthcare spending and hospital stays

World's largest AI-powered medical research network launched by OWKIN

Study assesses safety and efficacy of new treatment for pancreatic cancer

Unraveling the complexity of cancer biology can prompt new avenues for drug development

The EORTC Brain Tumor Group and Protagen AG collaborate to study immuno-competence of long-term glioblastoma survivors

New collaborative partnership in quest of novel antibiotics

Integral Molecular and Merus collaborate to develop bispecific antibody therapeutics

ESMO Immuno-Oncology Congress showcases novel technologies set to benefit many cancer patients

Researchers gain new insights into pediatric tumors

New artificial intelligence-based system to differentiate between different types of cancer cells

New data from TAILORx trial confirms lack of chemo benefit regardless of race or ethnicity

Exercise program during adjuvant breast cancer treatment may provide cardiovascular benefits

eBook: Liquid biopsy in cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News